SCHEMBL5212439

SCHEMBL5212439

Clc1cccc2c(Br)c(-c3ccco3)nn12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
BLM P54132 3/20 0.45
TSHR P16473 2/20 0.45
MAPK1 P28482 1/20 0.45
ALDH1A1 P00352 4/20 0.41
HPGD P15428 4/20 0.41
POLB P06746 4/20 0.41
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
PKM P14618 2/20 0.41
ALOX15 P16050 2/20 0.41
CASP1 P29466 2/20 0.41
PTPN7 P35236 2/20 0.41
RECQL P46063 2/20 0.41
CASP7 P55210 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
LMNA P02545 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5208134 0.79 MEN1 (0.42) MAPTMEN1KMT2ABLMTSHR
SCHEMBL5209233 0.74 KMT2A (0.41) MAPTMEN1KMT2ABLMTSHR
SCHEMBL5211466 0.74 KMT2A (0.38) MAPTMEN1KMT2ABLMTSHR
SCHEMBL5209423 0.73 ADORA3 (0.43) MAPTMEN1KMT2ABLMTSHR
SCHEMBL5457630 0.72 MAPK14 (0.63) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL5210473 0.67 PTGS1 (0.46) MAPTMEN1KMT2ABLMTSHR
SCHEMBL21621286 0.63 PIK3R1 (0.51) MAPTMEN1KMT2ABLMTSHR
SCHEMBL29947091 0.63 PIK3R1 (0.51) MAPTMEN1KMT2ABLMTSHR
SCHEMBL31612378 0.61 MAPT (0.54) MAPTMEN1KMT2ABLMTSHR
SCHEMBL2114343 0.61 MAPT (1.00) MAPTMEN1KMT2ABLMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453830-B1 PYRAZOLO-PYRIDINE DERIVATIVES AS ANTIHERPES AGENTS SMITHKLINE BEECHAM CORP (US) 2007-09-12 EP disclosed
US-20070161653-A1 Pyrazolo-Pyridine Derivatives As Antiherpes Agents GUDMUNDSSON KRISTJAN 2007-07-12 US disclosed
US-7199120-B2 Pyrazolo-pyridine derivatives as antiherpes agents SMITHKLINE BEECHAM CORPORATION (US) 2007-04-03 US disclosed
US-20040248903-A1 Pyrazolo-pyridine derivatives as antiherpes agents SMITHKLINE BEECHAM CORPORATION 2004-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161653-A1 Pyrazolo-Pyridine Derivatives As Antiherpes Agents HRH4, HRH2, HRH1 MAPT 1616/4885MEN1 2749/4885KMT2A 1758/4885
US-20040248903-A1 Pyrazolo-pyridine derivatives as antiherpes agents HRH4, HRH1, HRH2 MAPT 1457/4885MEN1 2302/4885KMT2A 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.